Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease

Background/Aims: Lung dysfunction associates with increased mortality but the impact of chronic kidney disease (CKD) is less clear. We evaluated lung function and its association with mortality among individuals with normal to severely reduced glomerular filtration rate (GFR). Methods: 404 individua...

Full description

Bibliographic Details
Main Authors: Hideyuki Mukai, Pei Ming, Bengt Lindholm, Olof Heimbürger, Peter Barany, Peter Stenvinkel, Abdul Rashid Qureshi
Format: Article
Language:English
Published: Karger Publishers 2018-03-01
Series:Kidney & Blood Pressure Research
Subjects:
Online Access:https://www.karger.com/Article/FullText/488699
id doaj-8c5604a53e624ec5966027dd865b357a
record_format Article
spelling doaj-8c5604a53e624ec5966027dd865b357a2020-11-25T03:18:31ZengKarger PublishersKidney & Blood Pressure Research1420-40961423-01432018-03-0143252253510.1159/000488699488699Lung Dysfunction and Mortality in Patients with Chronic Kidney DiseaseHideyuki MukaiPei MingBengt LindholmOlof HeimbürgerPeter BaranyPeter StenvinkelAbdul Rashid QureshiBackground/Aims: Lung dysfunction associates with increased mortality but the impact of chronic kidney disease (CKD) is less clear. We evaluated lung function and its association with mortality among individuals with normal to severely reduced glomerular filtration rate (GFR). Methods: 404 individuals representing GFR category G1 (n=31; GFR >90 mL/min/1.73 m2), G2 (n=46), G3 (n=33), G4 (n=49) and G5 (n=245; GFR< 15 mL/min/1.73 m2) underwent spirometry yielding lung function indices forced vital capacity (FVC), forced expiratory volume in the first second (FEV1) and peak expiratory flow (PEF). Associations of lung function indices expressed as percentages of predicted values (%FEV1, %FVC and %PEF) with 5-year mortality were analyzed by competing-risk regression models. Results: The prevalence of obstructive (6% in G1 and 11% in G5) and especially restrictive (9% in G1 to 36% in G5) lung dysfunction increased with declining GFR and with higher comorbidity burden. In patients (n=22) with protein-energy wasting, inflammation and cardiovascular disease, the prevalence of restrictive lung function was 64%. The highest tertiles of % FEV1 and %FVC associated with lower sub-hazard ratios (sHR) for all-cause mortality, 0.49 (95% CI, 0.27-0.88)) and 0.56 (95% CI, 0.32-0.98), and that of %FEV1 also with lower cardiovascular mortality risk (sHR 0.16; 95%CI 0.04-0.69) after adjusting for multiple confounders. Restrictive lung dysfunction (FEV1/FVC ≥ 0.70, and %FVC < 80) associated with increased mortality risk (sHR 1.80, 95%CI, 1.04-3.13) while the association with obstructive lung impairment was not statistically significant. Conclusion: Lung dysfunction and in particular restrictive lung dysfunction associates with degree of renal function impairment and presence of comorbidities, and is an independent predictor of increased mortality in CKD patients.https://www.karger.com/Article/FullText/488699GFR categoriespulmonary functionmortality
collection DOAJ
language English
format Article
sources DOAJ
author Hideyuki Mukai
Pei Ming
Bengt Lindholm
Olof Heimbürger
Peter Barany
Peter Stenvinkel
Abdul Rashid Qureshi
spellingShingle Hideyuki Mukai
Pei Ming
Bengt Lindholm
Olof Heimbürger
Peter Barany
Peter Stenvinkel
Abdul Rashid Qureshi
Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease
Kidney & Blood Pressure Research
GFR categories
pulmonary function
mortality
author_facet Hideyuki Mukai
Pei Ming
Bengt Lindholm
Olof Heimbürger
Peter Barany
Peter Stenvinkel
Abdul Rashid Qureshi
author_sort Hideyuki Mukai
title Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease
title_short Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease
title_full Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease
title_fullStr Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease
title_full_unstemmed Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease
title_sort lung dysfunction and mortality in patients with chronic kidney disease
publisher Karger Publishers
series Kidney & Blood Pressure Research
issn 1420-4096
1423-0143
publishDate 2018-03-01
description Background/Aims: Lung dysfunction associates with increased mortality but the impact of chronic kidney disease (CKD) is less clear. We evaluated lung function and its association with mortality among individuals with normal to severely reduced glomerular filtration rate (GFR). Methods: 404 individuals representing GFR category G1 (n=31; GFR >90 mL/min/1.73 m2), G2 (n=46), G3 (n=33), G4 (n=49) and G5 (n=245; GFR< 15 mL/min/1.73 m2) underwent spirometry yielding lung function indices forced vital capacity (FVC), forced expiratory volume in the first second (FEV1) and peak expiratory flow (PEF). Associations of lung function indices expressed as percentages of predicted values (%FEV1, %FVC and %PEF) with 5-year mortality were analyzed by competing-risk regression models. Results: The prevalence of obstructive (6% in G1 and 11% in G5) and especially restrictive (9% in G1 to 36% in G5) lung dysfunction increased with declining GFR and with higher comorbidity burden. In patients (n=22) with protein-energy wasting, inflammation and cardiovascular disease, the prevalence of restrictive lung function was 64%. The highest tertiles of % FEV1 and %FVC associated with lower sub-hazard ratios (sHR) for all-cause mortality, 0.49 (95% CI, 0.27-0.88)) and 0.56 (95% CI, 0.32-0.98), and that of %FEV1 also with lower cardiovascular mortality risk (sHR 0.16; 95%CI 0.04-0.69) after adjusting for multiple confounders. Restrictive lung dysfunction (FEV1/FVC ≥ 0.70, and %FVC < 80) associated with increased mortality risk (sHR 1.80, 95%CI, 1.04-3.13) while the association with obstructive lung impairment was not statistically significant. Conclusion: Lung dysfunction and in particular restrictive lung dysfunction associates with degree of renal function impairment and presence of comorbidities, and is an independent predictor of increased mortality in CKD patients.
topic GFR categories
pulmonary function
mortality
url https://www.karger.com/Article/FullText/488699
work_keys_str_mv AT hideyukimukai lungdysfunctionandmortalityinpatientswithchronickidneydisease
AT peiming lungdysfunctionandmortalityinpatientswithchronickidneydisease
AT bengtlindholm lungdysfunctionandmortalityinpatientswithchronickidneydisease
AT olofheimburger lungdysfunctionandmortalityinpatientswithchronickidneydisease
AT peterbarany lungdysfunctionandmortalityinpatientswithchronickidneydisease
AT peterstenvinkel lungdysfunctionandmortalityinpatientswithchronickidneydisease
AT abdulrashidqureshi lungdysfunctionandmortalityinpatientswithchronickidneydisease
_version_ 1724626261381218304